Chiron Real Estate price to sales ratio XRN
Market value divided by revenue over the last twelve months, since 2026.
- Today, Nov 2, 2026
- 2.6×
- Peer median
- 4.0×
Chiron Real Estate's price to sales ratio is 2.6× as of Nov 2, 2026.
It has traded since Jan 30, 2026, and over that time its price to sales ratio ranged from 2.6× in Oct 2026 to 3.4× in Feb 2026.
The median for 10 specialty REITs of a similar size is 4.0×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 2.6× | 2.6× | 3.4× |
Against its peers
Companies in REIT - Specialty nearest Chiron Real Estate's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| XRNChiron Real Estate | 2.6× |
| CHCTCommunity Healthcare Trust | 3.0× |
| BRSPBrightSpire Capital | n/m |
| TCITranscontinental Realty Investors | 8.9× |
| FPIFarmland Partners | 7.2× |
| OLPOne Liberty Properties | n/m |
| TRTXTPG RE Finance Trust | 3.6× |
| UHTUniversal Health Realty Income Trust | 5.4× |
| PINEAlpine Income Property Trust | 4.0× |
| ARIApollo Commercial Real Estate Finance | 1.2× |
| IVRInvesco Mortgage Capital | n/m |
| Peer median | 4.0× |
Where Chiron Real Estate ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Chiron Real Estate
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.